Attention-Deficit/Hyperactivity Disorder Treatment Patterns and Association With Clinical Outcomes in Adolescents and Young Adults with Co-Occurring Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder: A Retrospective Analysis
Journal of the American Academy of Child & Adolescent Psychiatry · 2026-10 · 65 (10) · 1273-1284
DOI: 10.1016/j.jaac.2025.12.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Child & Adolescent Psychiatry, 2026-10. Verfasst von Raman Baweja und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pennsylvania State College of Medicine, Hershey, Pennsylvania. Electronic address: rbaweja@pennstatehealth.psu.edu. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Substance-Related Disorders, Central Nervous System Stimulants, Practice Patterns, Physicians'. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIDA NIH HHS, National Center for Advancing Translational Sciences.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
OBJECTIVE: This study evaluated the impact of co-occurring substance use disorder (SUD) on attention-deficit/hyperactivity disorder (ADHD) treatment patterns and examined clinical outcomes associated with ADHD treatment in adolescents and young adults with both ADHD and SUD. METHOD: This retrospective cohort study used TriNetX US Collaborative Network data on 1.23 million individuals 15 to 25 years of age who were diagnosed with ADHD from 2007 to 2024. About 23% (n = 288,159) had co-occurring SUD. Prescription patterns for ADHD medications and associated clinical outcomes were analyzed over 1 year. Relative risks (RRs), hazard ratios (HRs), and 95% CIs were calculated using propensity score matching and Cox proportional hazards models to adjust for confounders. RESULTS: Central nervous system (CNS) stimulant prescriptions were less frequent in the ADHD with SUD cohort (RR = 0.63, 95% CI = 0.62-0.63), whereas new bupropion prescriptions were slightly more frequent (RR = 1.05, 95% CI = 1.02-1.08) compared with ADHD without SUD. In ADHD with SUD, ADHD treatment (including prescriptions for CNS stimulants and nonstimulants) was associated with fewer hospitalizations, reduced emergency care, lower risk of suicidal ideation/attempts (range of RRs = 0.74-0.82), and continuous use of psychiatric services (RR = 1.23), but fewer methadone prescriptions (RR = 0.74). Compared with nonstimulants, stimulant treatment was associated with fewer hospitalizations, accidental overdoses, and suicidal ideation/attempts (range of RRs = 0.63-0.79). Overall, ADHD treatment was associated with a 30% lower risk of mortality (aHR = 0.70, 95% CI = 0.65-0.75). CONCLUSION: Clinicians appear to be hesitant to prescribe CNS stimulants in the context of SUD; however, these findings align with clinical trials suggesting potential benefits of ADHD medication for individuals with co-occurring SUD. Bridging the gap between clinical practice and the evidence base will require ongoing research, clinician education, and policy change. PLAIN LANGUAGE SUMMARY: This study examined how treatment patterns and outcomes for adolescents and young adults co-occurring attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD). The authors conducted a retrospective cohort study using TriNetX US Collaborative Network data (N = 288,159 youths with ADHD and a co-occurring SUD). Adolescents and young adults with both conditions were less likely to receive ADHD medication, particularly stimulants. However, ADHD treatment was associated with fewer hospitalizations, lower risk of intubation, and reduced mortality. Across multiple outcomes, stimulant medications demonstrated more favorable clinical outcomes than nonstimulants, suggesting potential benefits of certain ADHD medications for individuals with co-occurring SUD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pennsylvania State College of Medicine, Hershey, Pennsylvania. Electronic address: rbaweja@pennstatehealth.psu.edu.
- Pennsylvania State College of Medicine, Hershey, Pennsylvania.
- Mayo Clinic, Rochester, Minnesota.
- University of California San Diego, La Jolla, California.
- University of Pittsburgh, Pittsburgh, Pennsylvania.
- Massachusetts General Hospital, Boston, Massachusetts.
Förderung
- NCATS NIH HHS
- NIDA NIH HHS
- National Center for Advancing Translational Sciences
- National Institutes of Health
- National Institute on Drug Abuse
- U.S. Food and Drug Administration
- Mayo Clinic
- Children's Hospital Association
Zitieren
APA
Baweja, R., Waschbusch, D. A., Padilla, F. M., Baweja, R., Singh, B., Pelham, W. E., Molina, B. S. G., Wilens, T. E., & Waxmonsky, J. G. (2026). Attention-Deficit/Hyperactivity Disorder Treatment Patterns and Association With Clinical Outcomes in Adolescents and Young Adults with Co-Occurring Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder: A Retrospective Analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 65(10), 1273-1284. https://doi.org/10.1016/j.jaac.2025.12.003
Vancouver
Baweja R, Waschbusch DA, Padilla FM, Baweja R, Singh B, Pelham WE, et al. Attention-Deficit/Hyperactivity Disorder Treatment Patterns and Association With Clinical Outcomes in Adolescents and Young Adults with Co-Occurring Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder: A Retrospective Analysis. Journal of the American Academy of Child & Adolescent Psychiatry. 2026;65(10):1273-1284. doi:10.1016/j.jaac.2025.12.003
BibTeX
@article{Baweja2026,
author = {Baweja, Raman and Waschbusch, Daniel A and Padilla, Felix M and Baweja, Ritika and Singh, Balwinder and Pelham, William E and Molina, Brooke S G and Wilens, Timothy E and Waxmonsky, James G},
title = {Attention-Deficit/Hyperactivity Disorder Treatment Patterns and Association With Clinical Outcomes in Adolescents and Young Adults with Co-Occurring Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder: A Retrospective Analysis},
journal = {Journal of the American Academy of Child & Adolescent Psychiatry},
year = {2026},
volume = {65},
number = {10},
pages = {1273--1284},
doi = {10.1016/j.jaac.2025.12.003}
}
EUVIMED